超敏C反应蛋白与新发脑出血关系研究

doi:10.3969/j.issn.1673-5765.2021.07.005

摘要/Abstract

摘要： 目的探讨超hs-CRP水平与新发脑出血事件的相关性。方法连续纳入2006年6月-2007年10月开滦社区的体检者，基线期完善问卷调查、体格检查及实验室检查。每24个月对受检者进行一次面对面随访，截至2017年12月31日，记录所有受检者随访期间新发脑出血事件类型及时间，按照是否出现新发脑出血事件分为新发脑出血组及对照组。将两组基线期一般临床资料、既往病史、体检结果、hs-CRP等实验室检查结果进行比较，采用Cox比例风险回归模型评估hs-CRP水平对新发脑出血事件的影响，同时进一步分析不同性别人群中hs-CRP对新发脑出血事件的影响。结果研究共纳入受试者87 242人，随访期间出现新发脑出血事件者829人。Cox比例风险回归模型分析发现，高hs-CRP水平是女性人群中新发脑出血的独立危险因素（HR 1.199，95%CI 1.040～1.383， P＝0.0125）。结论高hs-CRP水平可能会增加脑出血事件的发生风险，尤其在女性人群中更应引起关注。

文章导读： 本研究通过对大样本健康人群十年的随访发现，基线hs-CRP水平可能与新发脑出血事件有关，特别是在女性人群中，升高的hs-CRP可能是新发脑出血事件的独立危险因素。

关键词: 超敏C反应蛋白; 炎症因子; 脑出血; 女性

Abstract: Objective To investigate the relationship between hs-CRP level and intracerebral hemorrhage (ICH). Methods This study enrolled the participants from June 2006 to October 2007 in Kailuan study, and all the subjects finished the questionnaire, physical examination and laboratory examinations at the baseline. The face-to-face follow-up were conducted every two years. The new ICH events during the follow-up were recorded until December 31, 2017, and the subjects were divided to new ICH group and control group according to ICH occurring or not . The baseline data including hs- CRP level between the two groups were compared. Cox regression analysis was used to analyze the effect of hs-CRP level on new ICH event. The effect of hs-CRP level on the new ICH event in different gender sub-groups was analyzed as well. Results A total of 87 242 participants were finally included in this study, and new ICH event occurred in 829 participants. Cox regression analysis showed that high hs-CRP level was an independent risk factor for ICH in women subgroup (HR 1.199, 95%CI 1.040-1.383, P =0.0125). Conclusions High hs-CRP level may increase the risk of ICH event, especially in women.

Key words: Hypersensitive C-reaction protein; Inflammation factor; Intracerebral hemorrhage;Women

王丹丹, 王晶, 王安心, 张怡君, 赵性泉. 超敏C反应蛋白与新发脑出血关系研究[J]. 中国卒中杂志, 2021, 16(07): 664-669.

WANG Dan-Dan, WANG Jing, WANG An-Xin, ZHANG Yi-Jun, ZHAO Xing-Quan. Relationship between Hypersensitive C-reaction Protein and Intracerebral Hemorrhage[J]. Chinese Journal of Stroke, 2021, 16(07): 664-669.

参考文献

[1] GBD 2016 Stroke Collaborators. Global，regional，
and national burden of stroke，1990-2016：a
systematic analysis for the global burden of disease
study 2016[J]. Lancet Neurol，2019，18（5）：439-
458.
[2] 王拥军，李子孝，谷鸿秋，等. 中国卒中报告2019（中
文版）（1）[J]. 中国卒中杂志，2020，15（10）：1037-
1043.
[3] WU S M，WU B，LIU M，et al. Stroke in China：
advances and challenges in epidemiology，prevention，
and management[J]. Lancet Neurol，2019，18（4）：
394-405.
[4] YU H，HUANG Y，CHEN X Y，et al. Highsensitivity
C-reactive protein in stroke patients-the
importance in consideration of influence of multiple
factors in the predictability for disease severity and
death[J/OL]. J Clin Neurosci，2017，36：12-19[2020-
12-09]. https：//doi.org/10.1016/j.jocn.2016.10.020.
[5] ZHOU Y，HAN W，GONG D，et al. hs-CRP in
stroke：a meta-analysis[J/OL]. Clin Chim Acta，2016，
453：21-27[2020-12-09]. https：//doi.org/10.1016/j.
cca.2015.11.027.
[6] ZHANG Q，ZHOU Y，GAO X，et al. Ideal
cardiovascular health metrics and the risks of
ischemic and intracerebral hemorrhagic stroke[J].
Stroke，2013，44（9） 2451-2456.
[7] PEARSON T A，MENSAH G A，ALEXANDER R
W，et al. Markers of inflammation and cardiovascular
disease：application to clinical and public health
practice：a statement for healthcare professionals
from the Centers for Disease Control and Prevention
and the American Heart Association[J]. Circulation，
2003，107（3）：499-511.
[8] HEMPHILL J C 3rd，GREENBERG S
M，ANDERSON C S，et al. Guidelines for
the management of spontaneous intracerebral
hemorrhage：a guideline for healthcare professionals
from the American Heart Association/American
Stroke Association[J]. Stroke，2015，46（7）：2032-
2060.
[9] KARIM M A，KARTSONAKI C，BENNETT D
A，et al. Systemic inflammation is associated with
incident stroke and heart disease in East Asians[J].
Sci Rep，2020，10（1）：5605.
[10] YOSHINAGA R，DOI Y，AYUKAWA K，et al.
High-sensitivity C reactive protein as a predictor of
inhospital mortality in patients with cardiovascular
disease at an emergency department：a retrospective
cohort study[J/OL]. BMJ Open，2017，7（10）：
e015112[2020-12-09]. https：//doi.org/10.1136/
bmjopen-2016-015112.
[11] SU B J，DONG Y，TAN C C，et al. Elevated hs-CRP
levels are associated with higher risk of intracranial
arterial stenosis[J]. Neurotox Res，2020，37（2）：
425-432.
[12] ROMERO F R，CATANEO D C，CATANEO A J.
C-reactive protein and vasospasm after aneurysmal
subarachnoid hemorrhage[J]. Acta Cir Bras，2014，29
（5）：340-345.
[13] TAJFARD M，TAVAKOLY SANY S B，AVAN

A，et al. Relationship between serum high

sensitivity C-reactive protein with angiographic
severity of coronary artery disease and traditional
cardiovascular risk factors[J]. J Cell Physiol，2019，
234（7）：10289-10299.
[14] DI NAPOLI M，GODOY D A，CAMPI V，et al.
C-reactive protein in intracerebral hemorrhage：
time course，tissue localization，and prognosis[J].
Neurology，2012，79（7）：690-699.
[15] LÖPPÖNEN P，QIAN Q，TETRI S，et al. Predictive
value of C-reactive protein for the outcome after
primary intracerebral hemorrhage[J]. J Neurosurg，
2014，121（6）：1374-1379.
[16] DI NAPOLI M，PARRY-JONES A R，SMITH C J，
et al. C-reactive protein predicts hematoma growth
in intracerebral hemorrhage[J]. Stroke，2014，45（1）：
59-65.
[17] BERNSTEIN J E，SAVLA P，DONG F，et al.
Inflammatory markers and severity of intracerebral
hemorrhage[J/OL]. Cureus，2018，10（10）：
e3529[2020-12-09]. https：//doi.org/10.7759/cureus.
3529.
[18] LIU Y F，WANG J，ZHANG L Q，et al. Relationship
between C-reactive protein and stroke：a large
prospective community based study[J/OL]. PLoS
One，2014，9（9）：e107017[2020-12-09]. https：//doi.
org/10.1371/journal.pone.0107017.
[19] MOSCA L，BARRETT-CONNOR E，WENGER N
K. Sex/gender differences in cardiovascular disease
prevention：what a difference a decade makes[J].
Circulation，2011，124（19）：2145-2154.
[20] RIDKER P M，HENNEKENS C H，BURING
J E. C-reactive protein and other markers of
inflammation in the prediction of cardiovascular
disease in women[J]. N Engl J Med，2000，342（12）：
836-843.